Literature DB >> 25904771

The solution to better preservation of the peritoneal membrane still lies hidden in the solution.

Dirk G Struijk1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25904771      PMCID： PMC4406306          DOI： 10.3747/pdi.2015.00032

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN： 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  34 in total

1.  Impact of a low-glucose peritoneal dialysis regimen on fibrosis and inflammation biomarkers.

Authors:  Susan Yung; Sing Leung Lui; Chris K F Ng; Andrew Yim; Maggie K M Ma; Kin Yee Lo; Chik Cheung Chow; Kwok Hong Chu; Wai Leung Chak; Man Fai Lam; Chun Yu Yung; Terence P S Yip; Sunny Wong; Colin S O Tang; Flora S K Ng; Tak Mao Chan
Journal:  Perit Dial Int       Date:  2015 Mar-Apr       Impact factor: 1.756

Review 2.  Effect of biocompatible peritoneal dialysis solution on residual renal function: a systematic review of randomized controlled trials.

Authors:  Eun-Young Seo; Sook Hee An; Jang-Hee Cho; Hae Sun Suh; Sun-Hee Park; Hyesun Gwak; Yong-Lim Kim; Hunjoo Ha
Journal:  Perit Dial Int       Date:  2014-09-02       Impact factor: 1.756

3.  High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells.

Authors:  H Ha; M R Yu; H B Lee
Journal:  Kidney Int       Date:  2001-02       Impact factor: 10.612

4.  Growth factors VEGF and TGF-beta1 in peritoneal dialysis.

Authors:  M M Zweers; D R de Waart; W Smit; D G Struijk; R T Krediet
Journal:  J Lab Clin Med       Date:  1999-08

5.  Toxicity of osmotic solutes on human mesothelial cells in vitro.

Authors:  A Breborowicz; H Rodela; D G Oreopoulos
Journal:  Kidney Int       Date:  1992-05       Impact factor: 10.612

Review 6.  Strategies to reduce glucose exposure in peritoneal dialysis patients.

Authors:  C J Holmes; T R Shockley
Journal:  Perit Dial Int       Date:  2000       Impact factor: 1.756

7.  Analysis of the prevalence and causes of ultrafiltration failure during long-term peritoneal dialysis: a cross-sectional study.

Authors:  Watske Smit; Natalie Schouten; Nicole van den Berg; Monique J Langedijk; Dirk G Struijk; Raymond T Krediet
Journal:  Perit Dial Int       Date:  2004 Nov-Dec       Impact factor: 1.756

8.  Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.

Authors:  M M Zweers; D G Struijk; W Smit; R T Krediet
Journal:  J Lab Clin Med       Date:  2001-02

9.  A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis.

Authors:  C D Mistry; R Gokal; E Peers
Journal:  Kidney Int       Date:  1994-08       Impact factor: 10.612

10.  A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.

Authors:  Sing Leung Lui; Susan Yung; Andrew Yim; Kui Man Wong; Kwok Lung Tong; Kin Shing Wong; Chun Sang Li; Tak Cheung Au; Wai Kei Lo; Yiu Wing Ho; Flora Ng; Colin Tang; Tak Mao Chan
Journal:  Am J Kidney Dis       Date:  2012-07-25       Impact factor: 8.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.